United Therapeutics Corp. (UTHR) PT Lowered to $203 at Ladenburg Thalmann
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $596.13 -0.43%
Rating Summary:
18 Buy, 9 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Rating Summary:
18 Buy, 9 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Join SI Premium – FREE
Ladenburg Thalmann analyst Matthew Kaplan lowered the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $203.00 (from $231.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs upgrades Sirius XM Radio to Buy with $37 target
- Scorpio Tankers (STNG) PT Raised to $105 at Evercore ISI
- Tempus AI Inc (TEM) PT Raised to $89 at Needham
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
